{"url_path":"/sec/ostx/8-k/2026-07-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","accession_number":"0001213900-26-075013","cik":"0001795091","ticker":"OSTX","issuer_name":"OS Therapies Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","primary_entity_key":"0001795091","primary_entity_name":"OS Therapies Inc"},"word_count":185,"has_tables":true,"body_markdown":"**Item 8.01 Other Events.**\n\n \n\nOn July 2, 2026, the Company\nissued a press release announcing the Private Placement and the appointment of Dr. Eagle to the Company’s board of directors, a\ncopy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\n**Forward-Looking Statements**\n\n \n\nThis Current Report on Form\n8-K, including Exhibit 99.1 hereto, contains forward-looking statements that involve risks and uncertainties, such as statements related\nto the intended use of the net proceeds from the Private Placement. The risks and uncertainties involved include the Company’s financial\nposition, market conditions and other risks detailed from time to time in the Company’s periodic reports and other filings with\nthe SEC. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company’s current expectations\nand assumptions and speak only as of the date of this Current Report on Form 8-K. The Company does not intend to revise or update any\nforward-looking statement in this Current Report on Form 8-K as a result of new information, future events or otherwise, except as required\nby U.S. federal securities law."}